Title |
Challenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo
|
---|---|
Published in |
Conflict and Health, May 2011
|
DOI | 10.1186/1752-1505-5-7 |
Pubmed ID | |
Authors |
Jacqueline Tong, Olaf Valverde, Claude Mahoudeau, Oliver Yun, François Chappuis |
Abstract |
Human African trypanosomiasis (HAT), or sleeping sickness, is a fatal neglected tropical disease if left untreated. HAT primarily affects people living in rural sub-Saharan Africa, often in regions afflicted by violent conflict. Screening and treatment of HAT is complex and resource-intensive, and especially difficult in insecure, resource-constrained settings. The country with the highest endemicity of HAT is the Democratic Republic of Congo (DRC), which has a number of foci of high disease prevalence. We present here the challenges of carrying out HAT control programmes in general and in a conflict-affected region of DRC. We discuss the difficulties of measuring disease burden, medical care complexities, waning international support, and research and development barriers for HAT. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 33% |
United States | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Scientists | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 3 | 3% |
United States | 1 | 1% |
Brazil | 1 | 1% |
Unknown | 88 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 21 | 23% |
Researcher | 17 | 18% |
Student > Ph. D. Student | 10 | 11% |
Student > Bachelor | 10 | 11% |
Other | 5 | 5% |
Other | 16 | 17% |
Unknown | 14 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 24 | 26% |
Agricultural and Biological Sciences | 13 | 14% |
Social Sciences | 13 | 14% |
Nursing and Health Professions | 6 | 6% |
Psychology | 4 | 4% |
Other | 18 | 19% |
Unknown | 15 | 16% |